Clinical trial
Effectiveness of Daily Chlorhexidine Bathing and Antibiotic and Proton Pump Inhibitor (PPI) Stewardship in Preventing Transmission and Infection Caused by Carbapenemase-Producing Enterobacteriaceae (CPE)
NCT07039955 is registered in ClinicalTrials.gov with Chuncheon Sacred Heart Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effectiveness of Daily Chlorhexidine Bathing and Antibiotic and Proton Pump Inhibitor (PPI) Stewardship in Preventing Transmission and Infection Caused by Carbapenemase-Producing Enterobacteriaceae (CPE)
- Lead sponsor
- Chuncheon Sacred Heart Hospital
- Phase
- Not applicable
- Overall status
- Enrolling by invitation
- Start date
- July 14, 2025
- Completion date
- August 31, 2026
- Enrollment
- 5,760 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
carbapenemase-producing enterobacteriaceae (cpe), healthcare-associated infections (hais)